Form D · Biotechnology
HOPE-Neuron Therapeutx, Inc.
Phoenix, AZ · CIK 0002143357
Offering snapshot reported Jul 2, 2026 · SEC filing
- Reported sold
- $150K Offering amount: $150K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $150K Reported outside-investor minimum
- First sale
- Jun 12, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2026 | Initial | $150,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-589398
Convertible Promissory Note, including underlying Capital Stock upon conversion and upon satisfaction of certain events.
Source: Form D, filed Jul 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karina Fedasz | Executive |
| Mark Forney | Executive |
| Ronald Howard Lane | Executive |
| John Louf | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4308 N 16 Th Ave
Phoenix, AZ, 85015
Phone: (305) 239-7657
Phoenix, AZ, 85015
Phone: (305) 239-7657